Logo image of ATNM

ACTINIUM PHARMACEUTICALS INC (ATNM) Stock Earnings & Estimates

USA - NYSE Arca - NYSEARCA:ATNM - US00507W2061 - Common Stock

1.34 USD
-0.01 (-0.74%)
Last: 1/14/2026, 11:22:23 AM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
ATNM revenue by date.ATNM revenue by date.
1.144M1.03M
-9.97%
81K
-92.14%
193.117K
-100.00%
45.9K
-100.00%
47.544M43.678M
-8.13%
125.24M
186.73%
209.25M
67.08%
301.73M
44.20%
392.37M
30.04%
550.42M
40.28%
EBITDA
YoY % growth
ATNM ebitda by date.ATNM ebitda by date.
-24.44M
-11.36%
-33.405M
-36.68%
-51.13M
-53.06%
-49.572M
18.01%
-37.332M
10.95%
-39.474M
-5.74%
-45.084M
-14.21%
-50.49M
-11.99%
N/AN/AN/AN/AN/A
EBIT
YoY % growth
ATNM ebit by date.ATNM ebit by date.
-24.964M
-11.48%
-34.104M
-36.61%
-51.92M
-52.24%
-47.784M
18.87%
-36.85M
12.52%
-40.044M
-8.67%
-26.799M
33.08%
-22.123M
17.45%
33.919M
253.32%
89.584M
164.11%
149.48M
66.86%
203.82M
36.35%
218.68M
7.29%
Operating Margin
ATNM operating margin by date.ATNM operating margin by date.
-2,182.17%-3,311.07%-64,098.77%-24,743.57%-80,282.22%N/A-56.37%-50.65%27.08%42.81%49.54%51.95%39.73%
EPS
YoY % growth
ATNM eps by date.ATNM eps by date.
-1.20
41.18%
-1.37
-14.17%
-1.84
-34.31%
-1.43
30.98%
-1.10
13.26%
-0.83
25.00%
-0.68
17.70%
-0.62
8.50%
-0.01
99.18%
0.45
9,000.00%
1.06
133.71%
1.44
36.06%
0.19
-86.57%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26
EPS
Q2Q % growth
-0.19
9.33%
-0.11
78.00%
0.36
262.27%
-0.11
29.87%
Revenue
Q2Q % growth
36.335M1.271M
1,312.22%
EBITDA
Q2Q % growth
-6.834M
6.49%
N/AN/AN/A
EBIT
Q2Q % growth
-8.045M
-7.20%
-8.804M
47.08%
8.93M
219.02%
-9.431M
6.65%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
-0.16
56.76%
-0.330.1751.49%
Q2 2025
Q2Q % growth
-0.22
42.11%
-0.360.1438.38%
Q1 2025
Q2Q % growth
-0.51
-64.52%
-0.28-0.23-80.18%
Q4 2024
Q2Q % growth
-0.21
38.24%
-0.380.1744.95%
Q3 2024
Q2Q % growth
-0.37
24.49%
-0.34-0.03-7.96%
Q2 2024
Q2Q % growth
-0.38
34.48%
-0.410.038.01%
Q1 2024
Q2Q % growth
-0.31
27.91%
-0.530.2241.55%
Q4 2023
Q2Q % growth
-0.34
20.93%
-0.550.2138.27%
Q3 2023
Q2Q % growth
-0.49
-28.95%
-0.540.059.64%
Q2 2023
Q2Q % growth
-0.58
-75.76%
-0.49-0.09-18.46%
Q1 2023
Q2Q % growth
-0.43
-86.96%
-0.430.000.42%
Q4 2022
Q2Q % growth
-0.43
-19.44%
-0.36-0.07-18.75%
Q3 2022
Q2Q % growth
-0.38
-26.67%
-0.31-0.07-22.15%
Q2 2022
Q2Q % growth
-0.33
-32.00%
0.52-0.85-164.07%
Q1 2022
Q2Q % growth
-0.23
20.69%
-0.320.0928.42%
Q4 2021
Q2Q % growth
-0.36
2.70%
-0.31-0.05-15.72%
Q3 2021
Q2Q % growth
-0.30
16.67%
-0.28-0.02-5.80%
Q2 2021
Q2Q % growth
-0.25
39.02%
-0.300.0517.61%
Q1 2021
Q2Q % growth
-0.29
67.78%
-0.300.013.07%
Q4 2020
Q2Q % growth
-0.37 -0.380.011.96%
Q3 2020
Q2Q % growth
-0.36 -0.450.0920.24%
Q2 2020
Q2Q % growth
-0.41 -0.410.00-0.52%
Q1 2020
Q2Q % growth
-0.90 -0.71-0.19-26.07%
ATNM Yearly EPS VS EstimatesATNM Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 0 -5 -10 -15
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q4 2024
Q2Q % growth

-100.00%
%
Q3 2023
Q2Q % growth

-100.00%
586.5K-586.5K-100.00%
Q2 2023
Q2Q % growth

-100.00%
%
Q1 2023
Q2Q % growth

-100.00%
%
Q4 2022
Q2Q % growth

-100.00%
1.055M-1.055M-100.00%
Q3 2022
Q2Q % growth
45K
-80.69%
500.647K-455.647K-91.01%
Q2 2022
Q2Q % growth
45K
-83.08%
17.85M-17.805M-99.75%
Q1 2022
Q2Q % growth
940K
51.13%
940K%
Q4 2021
Q2Q % growth
23K 81.6K-58.6K-71.81%
ATNM Yearly Revenue VS EstimatesATNM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2027 2028 2029 2030 2031 2032 2033 100M 200M 300M 400M 500M
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% 11.42% 0% 19.1%
RevenueN/A N/A 0% N/A